Erik C.J. Phernambucq

Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity

Erik C.J. Phernambucq, F. Spoelstra, W. Verbakel et al. · Annals of Oncology · 2010 · 42 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Tumor Cavitation in Patients With Stage III Non–Small-Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy: Incidence and Outcomes

Erik C.J. Phernambucq, Koen J. Hartemink, Egbert F. Smit et al. · Journal of Thoracic Oncology · 2012 · 38 citations

Medicine, Oncology, Surgery +10

Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer

Erik C.J. Phernambucq, David A. Palma, Andrew Vincent et al. · Lung Cancer · 2011 · 36 citations · Full text

Medicine, Oncology, Radiology +17

Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus

J. L. G. Blaauwgeers, Ingrid Kappers, Houke M. Klomp et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2013 · 22 citations

Medicine, Oncology, Surgery +9

Nutrition During Trimodality Treatment in Stage III Non-small Cell Lung Cancer: Not Only Important for Underweight Patients

Barbara S. van der Meij, Erik C.J. Phernambucq, Geert M. Fieten et al. · Journal of Thoracic Oncology · 2011 · 19 citations · Full text

Agriculture, Nutrition, Oncology +13